Earnings Call · Q4 FY2021·2022-03-21

Q4 21EPS -8.55%·Rev n/aQ3 21EPS -1.50%·Rev n/aQ2 21EPS -7.34%·Rev n/aQ1 21EPS +6.40%·Rev n/a⚠ consensus missing

UroGen Pharma Ltd. URGN

Vincent Perrone — Senior Director of Investor Relations

Liz Barrett — President and CEO

Mark Schoenberg — Chief Medical Officer

Jeff Bova — Chief Commercial Officer

Molly Henderson — Chief Financial Officer

+0.1%1d on move date+0.1% vs SPY3d−7.8%5d−4.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more URGN calls or request research access.

More URGN calls Browse calls Request research access